Skip to main content

Table 3 Publication status of included trials at 0, 2, and 3 years post-approval

From: Publication statuses of clinical trials supporting FDA-approved immune checkpoint inhibitors: a meta-epidemiological investigation

  0 years 2 years 3 years
Publication status, n (%) ICPi trials Other anticancer drug trials All trials ICPi trials Other anticancer drug trials All trials ICPi trials Other anticancer drug trials All trials
Full publication 6 (32) 35 (35) 41 (34) 11 (58) 68 (67) 79 (66) 15 (79) 71 (70) 86 (72)
Full report 0 10 (10) 10 (8) 2 (11) 12 (12) 14 (12) 2 (11) 11 (11) 13 (11)
Partial publication 5 (26) 5 (5) 10 (8) 5 (26) 6 (6) 11 (9) 2 (11) 7 (7) 9 (8)
Conference abstract 2 (11) 14 (14) 16 (13) 0 3 (3) 3 (3) 0 2 (2) 2 (2)
None 6 (32) 35 (35) 41 (34) 1 (5) 10 (10) 11 (9) 0 8 (8) 8 (7)
Unclear 0 2 (2) 2 (2) 0 2 (2) 2 (2) 0 2 (2) 2 (2)
  1. ICPi immune checkpoint inhibitor
\